SCA

Clinical trials for SCA explained in plain language.

Never miss a new study

Get alerted when new SCA trials appear

Sign up with your email to follow new studies for SCA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for SCA patients: expanded access to investigational drug troriluzole

Disease control AVAILABLE

This program offers the investigational drug troriluzole to people with spinocerebellar ataxia (SCA) who are not eligible for other trials. SCA is a rare, progressive disease that affects coordination and balance. The goal is to provide access to a potential treatment that may he…

Matched conditions: SCA

Sponsor: Biohaven Pharmaceuticals, Inc. • Aim: Disease control

Last updated May 17, 2026 06:17 UTC

SCA

Get alerted when new SCA trials appear

New hope for SCA patients: expanded access to investigational drug troriluzole